Piper Brian 4
4 · Aevi Genomic Medicine, Inc. · Filed May 16, 2018
Insider Transaction Report
Form 4
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2018-05-14+270,000→ 270,000 totalExercise: $1.51Exp: 2028-05-14→ Common Stock (270,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on May 14, 2019, then in 24 equal monthly installments on the 14th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer.